Physician profile
Seth Newman
NPI 1295727683
$11,541.86
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.60 · 2021: $35.98 · 2022: $149 · 2023: $145 · 2024: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,600 · Education: $4,000 · Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,600.00 |
| Education | $4,000.00 |
| Food and Beverage | $702.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,725.70 | 2024 | Progrip, V-Loc 180 |
| Intuitive Surgical, INC. | $4,396.49 | 2019-2024 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $265.76 | 2023-2024 | Oasis, Stravix Pl, Grafix Pl |
| Janssen Pharmaceuticals, INC | $78.58 | 2022-2024 | Xarelto |
| Baxter Healthcare | $38.04 | 2024 | Perclot |
| Davol INC. | $26.36 | 2021 | |
| Covidien LP | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.